Kiniksa Pharmaceuticals International, plc (KNSA)
$79.78+1.31%Close
BUYBULL · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $6.0B
- Beta
- 0.09
- P/E (TTM)
- 72.05
- Short % float
- 5.26%
- Days to cover
- 6.4
- SI change
- -2.5%
- 1W
- +5.26%
- 1M
- +4.31%
- vs SPY 1W
- +4.10%
- vs SPY 1M
- +1.32%
Industry peers
FMP comparable companies · ranked by market cap
- SYRESELLSpyre Therapeutics, Inc.$6.9BCRISISQ 10$79.90+7.25%
- IMVTSELLImmunovant, Inc.$6.2BCRISISQ 25$30.26+0.69%
- ORKASELLOruka Therapeutics, Inc.$4.7BCRISISQ -3$77.28+6.25%
- DNTHSELLDianthus Therapeutics, Inc.$4.6BCRISISQ 2$82.43-0.07%
- NRIXSELLNurix Therapeutics, Inc.$2.3BBEARQ 11$22.21+0.63%
- ANABSELLAnaptysBio, Inc.$1.4BCRISISQ 25$46.21-0.56%
- AVTXSELLAvalo Therapeutics, Inc.$706MCRISISQ -10$13.43+1.64%
- PHARSELLPharming Group N.V.$675MCRISISQ -1$9.53+2.73%
- ACRSSELLAclaris Therapeutics, Inc.$529MCRISISQ 9$3.79+1.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
